GlassScriptPhysician profile
Michael A Ferguson
NPI 1033189899
$4,476.53
in general payments reported to CMS, 2019-2025
12 companies · $339 in 2025
The $339 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $231 · 2021: $2,740 · 2022: $238 · 2023: $347 · 2024: $224 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $910.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $2,450.00 | 2021 | |
| Edwards Lifesciences Corporation | $595.02 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $520.69 | 2019-2025 | Impella |
| Abbott Laboratories | $416.76 | 2020-2025 | Mitraclip, Coroflow, Ensite |
| Cardiovascular Systems INC. | $117.92 | 2021 | |
| Shockwave Medical, INC | $100.58 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $99.24 | 2020-2024 | Rotapro |
| Philips North America LLC | $58.96 | 2020 | |
| Opsens INC. | $45.84 | 2021-2022 | |
| Terumo Medical Corporation | $31.89 | 2025 | Metacross Otw, Heartrail |
| Cardiva Medical, INC. | $27.71 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Chiesi USA, INC. | $11.92 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.